{"title":"癌症诊断和放射性核素治疗中的创新放射性药物","authors":"V. I. Chernov","doi":"10.31857/s0869587324010088","DOIUrl":null,"url":null,"abstract":"The article presents the development trends of nuclear medicine in oncology. It has been shown that the main trends in modern radiopharmaceutics are closely related to theranostics, i.e., the use of radiopharmaceuticals obtained on the basis of a single delivery vector labeled with diagnostic and therapeutic radionuclides. In nuclear medicine, this approach has found application for the individualization and planning of radionuclide therapy. The results of our own research aimed at the development of radiopharmaceuticals for the diagnosis and radionuclide therapy of cancer are presented.","PeriodicalId":344486,"journal":{"name":"Вестник Российской академии наук","volume":" 86","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Innovative radiopharmaceuticals in cancer diagnostics and radionuclide therapy\",\"authors\":\"V. I. Chernov\",\"doi\":\"10.31857/s0869587324010088\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article presents the development trends of nuclear medicine in oncology. It has been shown that the main trends in modern radiopharmaceutics are closely related to theranostics, i.e., the use of radiopharmaceuticals obtained on the basis of a single delivery vector labeled with diagnostic and therapeutic radionuclides. In nuclear medicine, this approach has found application for the individualization and planning of radionuclide therapy. The results of our own research aimed at the development of radiopharmaceuticals for the diagnosis and radionuclide therapy of cancer are presented.\",\"PeriodicalId\":344486,\"journal\":{\"name\":\"Вестник Российской академии наук\",\"volume\":\" 86\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Вестник Российской академии наук\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31857/s0869587324010088\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Вестник Российской академии наук","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31857/s0869587324010088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Innovative radiopharmaceuticals in cancer diagnostics and radionuclide therapy
The article presents the development trends of nuclear medicine in oncology. It has been shown that the main trends in modern radiopharmaceutics are closely related to theranostics, i.e., the use of radiopharmaceuticals obtained on the basis of a single delivery vector labeled with diagnostic and therapeutic radionuclides. In nuclear medicine, this approach has found application for the individualization and planning of radionuclide therapy. The results of our own research aimed at the development of radiopharmaceuticals for the diagnosis and radionuclide therapy of cancer are presented.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
